Farxiga vs Skyrizi
Side-by-side drug price comparison from Medicare Part D data
Verdict
Farxiga costs 94% less per claim than Skyrizi ($266.00 vs $4475.00). Farxiga has a generic alternative available. Total Medicare spending: Farxiga at $3.0B vs Skyrizi at $2.3B.
| Metric | Farxiga | Skyrizi |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $266* | $4,475 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $3.0B | $2.3B |
| Total Claims | 11,240,000 | 524,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 31.5%* | 42.8% |
| Generic Available | Yes | No |
| Condition | Diabetes | Autoimmune Diseases |
| Total Beneficiaries | 1,340,000 | 78,000 |
Farxiga costs 94% less per claim than Skyrizi ($266.00 vs $4475.00). Farxiga has a generic alternative available. Total Medicare spending: Farxiga at $3.0B vs Skyrizi at $2.3B.
Explore More
The side-by-side above pulls the CMS Medicare Part D Drug Spending data data for both Farxiga and Skyrizi. What follows is the interpretation — which specific axes carry the most weight for Farxiga versus Skyrizi, and which differences are large enough to influence a real decision.
Practical use of the comparison: read the data above, then drill into the individual Farxiga and Skyrizi detail pages for the underlying breakdown. A pairwise comparison answers the relative question; the per-entity pages answer the absolute question.
Source: CMS Medicare Part D Spending, 2026.